MetLife Whole and Term Life & Endowments — Issuances increased by 18.3% to $207.00M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 38.9%, from $149.00M to $207.00M. Over 4 years (FY 2021 to FY 2025), Whole and Term Life & Endowments — Issuances shows an upward trend with a 31.9% CAGR. This is a positive signal — higher values indicate stronger performance for this metric.
Higher issuance indicates strong sales growth and successful market penetration for new insurance products.
This metric tracks the new liabilities established during the period due to the issuance of new whole life, term life, o...
Commonly tracked as a key performance indicator for new business volume in life insurance.
met_segment_whole_and_term_life_endowments_issuances| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $52.00M | $52.00M | $52.00M | $38.00M | $68.00M | $40.00M | $85.00M | $141.00M | $187.00M | $286.00M | $115.00M | $153.00M | $116.00M | $117.00M | $172.00M | $149.00M | $141.00M | $165.00M | $175.00M | $207.00M |
| QoQ Change | — | +0.0% | +0.0% | -26.9% | +78.9% | -41.2% | +112.5% | +65.9% | +32.6% | +52.9% | -59.8% | +33.0% | -24.2% | +0.9% | +47.0% | -13.4% | -5.4% | +17.0% | +6.1% | +18.3% |
| YoY Change | — | — | — | — | +30.8% | -23.1% | +63.5% | +271.1% | +175.0% | +615.0% | +35.3% | +8.5% | -38.0% | -59.1% | +49.6% | -2.6% | +21.6% | +41.0% | +1.7% | +38.9% |